* 100 % of Funds Go To Metastatic Breast Cancer Research
BREAST FRIENDS FUND(BFF)
What is Metastatic
Sandy was initially diagnosed with Stage 3 breast cancer at the age of 37, on May 30, 2013.
She chose to have a bilateral mastectomy followed by 8 rounds of chemotherapy and 28 rounds of radiation.
Soon after the end of radiation treatment, Sandy was declared cancer-free.
Unfortunately, in April 2015, Sandy was no longer a breast cancer survivor. Sandy was told that the breast cancer had spread to her liver and she was now living with Stage 4 Metastatic Breast Cancer with no cure.
After being on FDA-approved treatment for 3 years in July 2018 Sandy was told her cancer is growing & she needed to find a new treatment.
Sandy enrolled in a clinical trial that did not work in battling her cancer. Sandy received another FDA-approved treatment beginning in October 2018.
Please keep our family in your prayers.
We will update more soon....
Tickets to Taste the Cure 2022- SOLD OUT,
but you can still Donate- Thank You
Sandy's with her current Medical team at Yale, on the left, Dr. Maryam Lustberg and on the right
Dr. Eric Winer
We are very Proud and Excited to Have Raised Over $ 725,000 in Total Contributions !!
Looking forward to seeing you at our Spring 2022 Events !
WTNH Interview May 10, 2202. Sandy's
with Alyssa Taglia, WTNH (left) and
Dr. Eric Winer (right)
Photo by Walt Jedziniak
Metastatic Breast Cancer Facts*:
*Metastatic Breast Cancer Network
When breast cancer spreads to other parts of the body, such as the bones, brain, liver, or lungs, it is called metastatic (also referred to as advanced or stage IV).
Although it is not curable, metastatic breast cancer can be treatable. Today, with new therapies, including biologic targeted treatments and novel drug combinations, women with metastatic breast cancer can live well for many years.
Who is Eric Winer
Eric P. Winer, MD, is the new director of Yale Cancer Center and physician-in-chief of Smilow Cancer Hospital. Dr. Winer, is also an Alfred Gilman Professor of Medicine and Pharmacology.
"Dr. Winer is a nationally-recognized leader in breast cancer care and research, a much sought-after mentor for younger clinicians and an advocate for his patients," said Marna Borgstrom, chief executive officer, Yale New Haven Health, in a press statement.
The new era in breast cancer research and care is focused on deepening the understanding of the complex interactions between the molecular underpinnings of cancer itself, the tumor’s microenvironment, and the body’s immune. Inspired by their patients, Dr. Winer and his team of physician-scientists have a bold, comprehensive approach focused on tackling the most vexing problems in breast cancer.
Philanthropic support is critical to the development of more effective strategies to better address treatment resistance and metastases.
Your philanthropic support is vital to accelerating this work.
Sandy's Story Updated February 2022
Sandy on New Channel 8 discussing her runner up status for the "Remarkable Woman" Award in CT- Feb 2020